SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS

• 收藏
• 分享

专利权人:

Enzo Biochem; Inc.

发明人:

Elazar Rabbani,James J. Donegan

申请号：

US16842814

公开号：

US20200230113A1

申请日:

2020.04.08

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/